作者: Samira Sadat Abolmaali , Ali Mohammad Tamaddon , Vahid Alimardani
DOI: 10.1155/2021/9495126
关键词:
摘要: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is exponentially spreading across the world, leading to an outbreak of serious viral pneumonia Antiviral therapies using chloroquine, hydroxychloroquine, and favipiravir have been approved by several countries increase quality life SARS-CoV-2-infected patients Currently, companies are intensively working on production (CoV) vaccines, resulting in some specific vaccines that for CoV infections humans Nevertheless, efficient prevention, treatment, diagnosis urgently required combat biological diversity rapid mutation Recently, significant attention has devoted nanoformulation or nanoparticles (NPs) due their features like high surface-to-volume ratio, drug encapsulation abilities, optical properties remove complications applied conventional therapeutic options In this regard, NPs increasingly used as new anti-CoV agents, vaccine carriers adjuvants, nanoscale biorecognition elements The present review article provides a comprehensive discussion recent updates regarding diagnosis, treatment different with emphasis application vaccination, [ABSTRACT FROM AUTHOR] Copyright Journal Nanomaterials property Hindawi Limited its content may not be copied emailed multiple sites posted listserv without copyright holder's express written permission However, users print, download, email articles individual use This abstract abridged No warranty given about accuracy copy Users should refer original published version material full (Copyright applies all Abstracts )